Estrogen replacement in surgical stage I and II endometrial cancer survivors (Q41243007)

28 September 2017

Estrogen replacement in surgical stage I and II endometrial cancer survivors (English)

1 reference

28 September 2017

1 reference

6

Berman ML

0 references

author name string

Chapman JA

1

1 reference

28 September 2017

DiSaia PJ

2

1 reference

28 September 2017

Osann K

3

1 reference

28 September 2017

Roth PD

4

1 reference

28 September 2017

Gillotte DL

5

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

American Journal of Obstetrics and Gynecology

28 September 2017

1 reference

28 September 2017

175

1 reference

28 September 2017

5

1 reference

28 September 2017

1195-1200

1 reference

The menopause: benefits and risks of estrogen-progestogen replacement therapy.

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Menopausal oestrogen therapy and protection from death from ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Survival among women with endometrial cancer: a comparison of estrogen users and nonusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Estrogen replacement therapy following treatment for stage I endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Risk factors for recurrence in clinically early endometrial carcinoma: an analysis of 183 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Cardiovascular health and disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

7 January 2021

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970027-3

10.1016/S0002-9378(96)70027-3

7 January 2021

Identifiers

DOI

1 reference

28 September 2017

1 reference